HU9302642D0 - Gp 160-derivatives and vaccine containing them or gp-160 itself - Google Patents

Gp 160-derivatives and vaccine containing them or gp-160 itself

Info

Publication number
HU9302642D0
HU9302642D0 HU9302642A HU9302642A HU9302642D0 HU 9302642 D0 HU9302642 D0 HU 9302642D0 HU 9302642 A HU9302642 A HU 9302642A HU 9302642 A HU9302642 A HU 9302642A HU 9302642 D0 HU9302642 D0 HU 9302642D0
Authority
HU
Hungary
Prior art keywords
derivatives
itself
vaccine containing
vaccine
Prior art date
Application number
HU9302642A
Other languages
Hungarian (hu)
Inventor
Frans Wijnendaele
Moncef Slaoui
Claudine Bruck
Myriam Francotte
Suzy Kummert
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of HU9302642D0 publication Critical patent/HU9302642D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9302642A 1991-03-21 1991-10-25 Gp 160-derivatives and vaccine containing them or gp-160 itself HU9302642D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919106048A GB9106048D0 (en) 1991-03-21 1991-03-21 Vaccines

Publications (1)

Publication Number Publication Date
HU9302642D0 true HU9302642D0 (en) 1994-01-28

Family

ID=10691984

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9302642A HU9302642D0 (en) 1991-03-21 1991-10-25 Gp 160-derivatives and vaccine containing them or gp-160 itself
HU9302642A HUT67011A (en) 1991-03-21 1991-10-25 Derivatives opf gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU9302642A HUT67011A (en) 1991-03-21 1991-10-25 Derivatives opf gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant

Country Status (12)

Country Link
CN (1) CN1064891A (en)
AP (1) AP368A (en)
BR (1) BR9107294A (en)
CZ (1) CZ195793A3 (en)
FI (1) FI934133A (en)
GB (1) GB9106048D0 (en)
HU (2) HU9302642D0 (en)
IL (1) IL99899A0 (en)
MA (1) MA22381A1 (en)
SK (1) SK82593A3 (en)
WO (1) WO1992016556A1 (en)
YU (1) YU174491A (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US6620414B2 (en) 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
ATE157882T1 (en) * 1993-03-23 1997-09-15 Smithkline Beecham Biolog VACCINE COMPOSITIONS CONTAINING 3-0-DEAZYLATED MONOPHOSPHORYL LIPID A
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
GB9706957D0 (en) 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
CN1304580C (en) * 2004-07-09 2007-03-14 楼伟 Surface glucoprotein gp160 of recombination expression human acquired immunity defact virus 1
EP1778725B1 (en) * 2004-07-23 2010-12-29 Novartis Vaccines and Diagnostics S.r.l. Polypeptides for oligomeric assembly of antigens
CN102657855B (en) 2004-09-22 2015-12-09 葛兰素史密丝克莱恩生物有限公司 For carrying out the immunogenic composition of staphylococcus inoculation
WO2008104803A2 (en) 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Proteins
EP2121745A2 (en) 2007-02-26 2009-11-25 Oxford Genome Sciences (UK) Limited Proteins
JP2012515544A (en) 2009-01-21 2012-07-12 オックスフォード ビオトヘラペウトイクス エルティーディー． PTA089 protein
EP2496605A1 (en) 2009-11-02 2012-09-12 Oxford Biotherapeutics Ltd. Ror1 as therapeutic and diagnostic target
RS55716B1 (en) 2011-06-28 2017-07-31 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
GB201213364D0 (en) 2012-07-27 2012-09-12 Glaxosmithkline Biolog Sa Purification process
GB201213652D0 (en) 2012-08-01 2012-09-12 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
GB201302447D0 (en) 2013-02-12 2013-03-27 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
US20180071380A1 (en) 2015-03-20 2018-03-15 The Regents Of The University Of Michigan Immunogenic compositions for use in vaccination against bordetella
CA3023672A1 (en) 2016-05-16 2017-11-23 Infectious Disease Research Institute Pegylated liposomes and methods of use
US11344619B2 (en) 2016-05-16 2022-05-31 Access To Advanced Health Institute Formulation containing TLR agonist and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein

Also Published As

Publication number Publication date
GB9106048D0 (en) 1991-05-08
CN1064891A (en) 1992-09-30
HUT67011A (en) 1995-01-30
WO1992016556A1 (en) 1992-10-01
CZ195793A3 (en) 1994-05-18
MA22381A1 (en) 1992-07-01
AP9100332A0 (en) 1992-01-31
IL99899A0 (en) 1992-08-18
SK82593A3 (en) 1994-01-12
BR9107294A (en) 1994-06-14
FI934133A0 (en) 1993-09-21
YU174491A (en) 1994-06-10
FI934133A (en) 1993-09-21
AP368A (en) 1994-10-28

Similar Documents

Publication Publication Date Title
HU9302642D0 (en) Gp 160-derivatives and vaccine containing them or gp-160 itself
GB9105992D0 (en) Vaccine
AP9300541A0 (en) Vaccines
AP9300530A0 (en) Vaccines
HU9202095D0 (en) Therapy and vaccine against aids
HUT64000A (en) Glass product and its use
HU9601191D0 (en) Vaccine design and production
GB9215233D0 (en) Vaccines
GB9214871D0 (en) Vaccines
GB9201023D0 (en) Vaccines
GB9213559D0 (en) Vaccines
GB9202933D0 (en) Vaccines
IL102290A0 (en) Ccv vaccine and its preparation
EP0505941A3 (en) Peptifluorin and neopeptifluorin
GB9226768D0 (en) Vaccines
GB9106540D0 (en) Aids therapy and vaccine
GB9211081D0 (en) Vaccines
GB9022330D0 (en) Aids therapy and vaccine
GB9020999D0 (en) Aids therapy and vaccine
GB9206788D0 (en) Vaccine
GB9307028D0 (en) Vaccine
GB9206786D0 (en) Vaccine
GB9206789D0 (en) Vaccine
GB9206797D0 (en) Vaccine
GB9213308D0 (en) Vaccine